禾信仪器(688622) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥45,134,456.52, representing a decrease of 9.26% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥12,333,292.83, a significant decline of 1,358.63% year-over-year[5]. - The basic earnings per share were -¥0.18, reflecting a decrease of 980.98% year-over-year[6]. - Operating profit for Q1 2022 was CNY -13,035,669.75, compared to CNY 607,875.95 in Q1 2021, indicating a significant decline[18]. - Net profit attributable to shareholders for Q1 2022 was CNY -12,333,292.83, compared to CNY 979,900.05 in Q1 2021[19]. - The net profit for Q1 2022 was a loss of CNY 11,247,405.33, compared to a net profit of CNY 8,296,083.35 in Q1 2021[27]. Research and Development - The total R&D investment amounted to ¥15,689,155.11, an increase of 74.76% compared to the previous year, accounting for 34.76% of operating revenue[6]. - Research and development expenses increased to CNY 15,689,155.11 in Q1 2022, up from CNY 6,322,622.74 in Q1 2021, reflecting a 148% increase[18]. - The company's research and development expenses increased significantly to CNY 11,912,986.57 in Q1 2022, compared to CNY 4,324,349.89 in Q1 2021, reflecting a focus on innovation[26]. Cash Flow and Liquidity - The net cash flow from operating activities was -¥80,054,513.03, with no applicable year-over-year comparison[5]. - Cash flow from operating activities for Q1 2022 was CNY -80,054,513.03, worsening from CNY -51,119,247.92 in Q1 2021[21]. - Cash flow from investing activities showed a net outflow of CNY -70,873,415.29 in Q1 2022, compared to CNY -18,056,931.00 in Q1 2021[22]. - Cash flow from operating activities showed a net outflow of CNY 64,519,478.16 in Q1 2022, compared to a net outflow of CNY 45,848,483.27 in Q1 2021[29]. - The net cash flow from investment activities was -$85,888,400, compared to -$14,996,419.23 in the previous year[30]. - The net cash flow from financing activities was -$1,332,393.37, contrasting with a positive $33,685,449.16 in the previous year[30]. - The ending cash and cash equivalents balance was $138,101,020.44, down from $91,713,890.53 year-over-year[30]. Assets and Liabilities - Total assets at the end of the reporting period were ¥845,143,201.99, a decrease of 9.26% from the end of the previous year[6]. - Current assets totaled CNY 562,274,547.91, down from CNY 650,785,057.03, indicating a decrease of about 13.56%[15]. - Total liabilities decreased to CNY 263,550,229.34 in Q1 2022 from CNY 338,112,699.44 in Q1 2021[18]. - The total equity attributable to shareholders was CNY 592,893,812.92 in Q1 2022, down from CNY 605,122,842.16 in Q1 2021[18]. - The total assets decreased to CNY 944,188,513.67 as of March 31, 2022, down from CNY 1,011,166,085.46 at the end of 2021[24]. - The total liabilities decreased to CNY 313,355,048.93 in Q1 2022, down from CNY 369,189,478.98 in Q1 2021[25]. Shareholder Structure and Strategic Initiatives - The company has a significant shareholder structure, with the top three shareholders holding a combined 44.35% of shares[11]. - The company is actively involved in strategic partnerships and investments, as indicated by the presence of various investment funds among its major shareholders[12]. Audit and Reporting - The report indicates no significant changes in the audit opinion type, maintaining a consistent approach in financial reporting[13]. - The company did not apply the new accounting standards starting from 2022[30].